Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tagwell is a molecular data company that utilizes synthetic DNA to create unique, invisible tags for physical products, enabling end-to-end supply chain transparency and authentication. By embedding digital information into physical matter at the molecular level, the company provides a forensic-grade solution for brand protection and anti-counterfeiting. Their platform allows manufacturers to track raw materials and finished goods throughout the global supply chain, ensuring provenance and compliance with ESG standards. Tagwell's technology leverages advancements in DNA synthesis and sequencing to bridge the gap between physical items and digital records. The company's solutions are applicable across various industries, including textiles, pharmaceuticals, and high-value consumer goods, where verifying authenticity is critical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TagWell.